Skip to content
Search

Latest Stories

Tata Motors posts $1bn loss as Jaguar costs hit bottom line

INDIA's Tata Motors announced a $1 billion loss Tuesday (18) despite a strong performance in the first quarter of 2021 as restructuring costs related to its British luxury car brand Jaguar Land Rover (JLR) hit the automaker's bottom line.

The Mumbai-headquartered firm posted a consolidated net loss of Rs 76bn during the January-March period, narrowing its losses from Rs 98.9 billion ($1.3bn) a year earlier.


The auto giant's revenues jumped 42 per cent, but exceptional costs worth £1.5bn ($2.13bn) related to its restructuring of JLR hurt its profitability.

"It was a strong and resilient all-round performance for us, despite the pandemic," P B Balaji, chief financial officer of Tata Motors, told reporters in a post-earnings conference call.

The company reported losses for three consecutive quarters last year, as the pandemic hammered demand in domestic and international markets.

But an easing of coronavirus restrictions saw the firm's revenues soar between October 2020 and March this year, as consumers splashed out on big-ticket items.

Commenting on JLR's performance, company chief executive officer Thierry Bollore said, "I have been encouraged by the company's resilience and strong recovery during a uniquely challenging year. Despite the pandemic, this year has also seen significant positive change culminating in February with the launch of our Reimagine strategy focused on reimagining our iconic British brands for a future of modern luxury by design."

Renewed lockdowns triggered by a ferocious second pandemic wave in India have dampened demand for vehicles yet again, with automobile makers including Tata Motors announcing temporary plant shutdowns.

"We will continue to remain vigilant about the evolving Covid situation," the company's CEO and managing director Guenter Butschek said in a statement.

Butschek is due to step down on June 30 of this year with uncertainty mounting over the firm's leadership after his replacement Marc Llistosella backed out of the role in March citing "personal reasons".

Britain's largest car manufacturer JLR reported a 20.5 per cent increase in revenue, led by a strong sales performance in China.

In February, JLR said it would lay off 2,000 employees in the financial year 2021-22, with a plan to go fully electric from 2025.

Tata Motors' share price has surged 78 per cent in 2021 so far, boosted by expectations of a sustained recovery in profitability.

"We expect Q1 FY22 to be relatively weak due to this as well as rising commodity inflation and expect to improve gradually from the second quarter. The business has demonstrated strong resilience in the face of adversity and its fundamentals are strong. We will remain agile to address these challenges and drive consistent, competitive and cash accretive growth over the medium to long term," Tata Motors said in a statement.

"The first priority in this situation is the safety and wellbeing of our employees. This is also expected to have a temporary adverse impact on the demand and supply situation. Consequently, the first half of the year is expected to be relatively weak."

Its shares closed over three per cent higher in Mumbai Tuesday ahead of the earnings announcement.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less